Assessing the Role of Mitochondrial Dysfunction in Primary Progressive Multiple Sclerosis
We could not find results for this trial
I know where the results areWhat it found
We found no results in the registry or in papers.
What it measured
Main measures
sequencing of mitochondrial DNA
3 years
Blood or spinal fluid markers
Who could take part
Relapsing and progressive · 18 and over
Inclusion Criteria: * Patients affected by primary progressive or relapsing remitting multiple sclerosis * Patient able to provide informed consent Exclusion Criteria: * Individuals with \< 18 years * Patients not affected by primary progressive or relapsing remitting multiple sclerosis
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The purpose of this project is to study genetic determinants of mitochondrial impairment in primary progressive multiple sclerosis. Specific aims are: 1) identify mitochondrial-related pathways, inherited and somatic mitochondrial DNA mutations associated to primary progressive multiple sclerosis, 2) functionally assess the identified genetic alterations.
Loading reviews and guidelines…
History
Started
Sept 2021
Main results due
Sept 2024
Finished
May 2025
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error